Free Trial
→ Caught on Camera: Elon Musk’s “Area 51” (From Brownstone Research) (Ad) Buy NBIX Stock  Free NBIX Stock Alerts

Neurocrine Biosciences (NBIX) SEC Filings & 10K Form

Neurocrine Biosciences logo
$114.00 -0.45 (-0.39%)
Closing price 03/27/2025 04:00 PM Eastern
Extended Trading
$113.16 -0.83 (-0.73%)
As of 03/27/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Neurocrine Biosciences SEC Filings

Export to Excel
DateFilerForm TypeView
03/06/2025
1:09 PM		Neurocrine Biosciences (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
02/14/2025
6:13 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:49 PM		Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:57 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:35 PM		Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:42 PM		Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:13 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:20 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:26 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:00 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:03 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/14/2025
5:08 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
3:33 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:33 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:33 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM		Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:34 PM		Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:35 PM		Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:35 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:35 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:36 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:36 PM		Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:36 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:37 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:38 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/13/2025
3:38 PM		Neurocrine Biosciences (Subject)
SHERWIN STEPHEN A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/12/2025
5:41 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:44 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:46 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:48 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:49 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:52 PM		Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
5:56 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
6:00 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/10/2025
3:51 PM		Neurocrine Biosciences (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/06/2025
3:04 PM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Elon Warns: Exec Order 14024 Targets Dollar (Ad)

Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.

Go Here to Learn What's Happening and How to Prepare >>
02/05/2025
5:50 AM		Neurocrine Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SCHEDULE 13G
02/04/2025
5:05 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:42 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:45 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:47 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:49 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:51 PM		Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:54 PM		Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:58 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:31 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2025
4:35 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:19 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:32 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:32 PM		Neurocrine Biosciences (Subject)
ROBERTS EIRY (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:33 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:34 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:29 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:27 PM		Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:28 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:28 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:28 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/31/2025
3:29 PM		BENEVICH ERIC (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/29/2025
6:03 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/27/2025
3:27 PM		GORMAN KEVIN CHARLES (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/15/2025
3:19 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/31/2024
3:17 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/20/2024
7:06 AM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2024
3:37 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/19/2024
3:47 PM		Neurocrine Biosciences (Issuer)
ROBERTS EIRY (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:29 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/03/2024
5:52 PM		Neurocrine Biosciences (Issuer)
Onyia Jude (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2024
12:41 PM		Neurocrine Biosciences (Subject)
Onyia Jude (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/07/2024
6:42 PM		Neurocrine Biosciences (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
6:52 PM		Gano Kyle (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/01/2024
7:31 AM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:02 AM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2024
6:04 AM		Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2024
8:54 AM		Neurocrine Biosciences (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
09/17/2024
3:21 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/13/2024
3:23 PM		Boyer David W. (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/28/2024
6:00 AM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/16/2024
4:00 PM		Neurocrine Biosciences (Issuer)
RASTETTER WILLIAM H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:06 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:12 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2024
4:21 PM		LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
4:16 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
4:18 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
4:40 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
9:51 AM		Neurocrine Biosciences (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/01/2024
6:03 AM		Neurocrine Biosciences (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Elon Warns: Exec Order 14024 Targets Dollar (Ad)

Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.

Go Here to Learn What's Happening and How to Prepare >>
08/01/2024
6:04 AM		Neurocrine Biosciences (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/18/2024
3:54 PM		LYONS GARY A (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:00 PM		Delaet Ingrid (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:12 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:45 PM		ABERNETHY MATT (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
3:41 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/16/2024
3:28 PM		Lippoldt Darin (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:29 PM		Cooke Julie (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/16/2024
3:29 PM		LYONS GARY A (Reporting)
Neurocrine Biosciences (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)

Remove Ads

Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:NBIX) was last updated on 3/28/2025 by MarketBeat.com Staff
From Our Partners
A $6.9 Trillion Cash Tsunami Is Coming – Move Your Money NOW
Expert: "Prepare For the Mother of All Melt-Ups" In the wake of Wall Street volatility, stock-picking legen...
Stansberry Research | Sponsored
Elon Warns: Exec Order 14024 Targets Dollar
Executive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...
Priority Gold | Sponsored
Why Elon put $51 million into this
Why Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT Scientists
True Market Insiders | Sponsored
Ex CIA predicts 40% “double crash” – April 11
The scientists here don’t study deadly viruses… directed energy weapons… or even weather control technology… ...
Paradigm Press | Sponsored
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
Warning: “DOGE Collapse” imminent
Elon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...
Altimetry | Sponsored
Trump Makes Major Crypto Announcement
Trump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...
Crypto 101 Media | Sponsored
Your Wealth is Under Attack
Please don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...
American Alternative | Sponsored